Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vestal Laboratories was a specialized healthcare company focused on infection prevention and skin care products. Based in St. Louis, Missouri, the firm developed a wide range of germicides, surgical scrubs, and environmental disinfectants for use in clinical and laboratory settings. The company was acquired by Bristol-Myers Squibb in 1986 and later merged with Calgon's wound care division to form Calgon Vestal Laboratories. In 1996, Steris Corporation acquired the business for approximately $361 million, integrating Vestal's legacy brands into its infection prevention portfolio. Today, the products originally developed by Vestal, such as Vesphene and Septisol, remain staples in hospital hygiene and sterilization protocols.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vestal Laboratories.